Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib studyXingsheng Hu, Yuankai Shi, Ziping Wang et al.|BMC Cancer|2023Cited by 8